The EasePoint is a spinal cord stimulation and nociceptive modulation implant designed for the long-term management of chronic pain conditions including neuropathy, post-injury sensitization, degenerative joint pain, and fibromyalgia-spectrum disorders. A primary electrode array is placed epidurally and delivers high-frequency electrical pulses at 10,000Hz — a frequency that interrupts pain signal transmission without producing the paresthesia (tingling sensation) associated with older spinal stimulator technology. A secondary processing node implanted subdermally at the wrist allows the user to adjust stimulation intensity across five discrete levels and to set pain threshold profiles for different activities, such as a reduced-suppression mode during physical therapy that allows the user to feel effort without debilitating pain. The device communicates with the primary array via encrypted short-range bioradio and logs pain event data for sharing with treating clinicians during follow-up appointments.

Chronic pain is one of the defining invisible crises of the lower tiers in GLMZ, where physically demanding labor, poor ergonomic conditions, inadequate early injury treatment, and the cumulative stress of Shelf-level living have produced a population with disproportionately high rates of musculoskeletal and neuropathic conditions. The EasePoint is NeuralPath's answer to a population that cannot afford to stop working but cannot function through the pain. For a Tier 1 warehouse handler with degenerative lumbar disease, the EasePoint does not cure anything — but it makes the workday possible, and it makes the rest of the day livable. Clinicians who work in the lower tiers describe it as one of the most impactful interventions they offer, not because it heals but because it restores the ability to participate in daily life.